Previous close | 6.40 |
Open | 6.90 |
Bid | 6.80 |
Ask | 7.10 |
Strike | 230.00 |
Expiry date | 2024-06-21 |
Day's range | 6.30 - 7.10 |
Contract range | N/A |
Volume | |
Open interest | 1.65k |
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives.
Evaluate the expected performance of Danaher (DHR) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.